Genes, pathways and metabolism in ageing

Cathy Slack, Linda Partridge

Research output: Contribution to journalArticle

Abstract

The isolation of single gene mutations that not only extend lifespan but also delay the onset of age-related pathology in model organisms has been instrumental in identifying key cellular processes that underlie ageing. Several of these mutations affect components of evolutionarily conserved metabolic pathways including the insulin-like growth factor/insulin signaling (IIS) and target of rapamycin (TOR) pathways. The challenges now are to understand the molecular and biochemical signaling events that mediate the observed increase in healthy lifespan when signaling via such pathways is perturbed, to identify potential targets for therapeutic interventions that could potentially be translated to humans with minimal side effects.

LanguageEnglish
Pagese87–e93
Number of pages13
JournalDrug Discovery Today: Disease Models
Volume10
Issue number2
Early online date28 Feb 2013
DOIs
Publication statusPublished - Jun 2013

Fingerprint

Mutation
Somatomedins
Sirolimus
Metabolic Networks and Pathways
Age of Onset
Genes
Insulin
Pathology
Therapeutics

Cite this

Slack, Cathy ; Partridge, Linda. / Genes, pathways and metabolism in ageing. 2013 ; Vol. 10, No. 2. pp. e87–e93.
@article{2b9f17d286134bdd8566eeba8d391def,
title = "Genes, pathways and metabolism in ageing",
abstract = "The isolation of single gene mutations that not only extend lifespan but also delay the onset of age-related pathology in model organisms has been instrumental in identifying key cellular processes that underlie ageing. Several of these mutations affect components of evolutionarily conserved metabolic pathways including the insulin-like growth factor/insulin signaling (IIS) and target of rapamycin (TOR) pathways. The challenges now are to understand the molecular and biochemical signaling events that mediate the observed increase in healthy lifespan when signaling via such pathways is perturbed, to identify potential targets for therapeutic interventions that could potentially be translated to humans with minimal side effects.",
author = "Cathy Slack and Linda Partridge",
year = "2013",
month = "6",
doi = "10.1016/j.ddmod.2013.01.002",
language = "English",
volume = "10",
pages = "e87–e93",
number = "2",

}

Genes, pathways and metabolism in ageing. / Slack, Cathy; Partridge, Linda.

Vol. 10, No. 2, 06.2013, p. e87–e93.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genes, pathways and metabolism in ageing

AU - Slack, Cathy

AU - Partridge, Linda

PY - 2013/6

Y1 - 2013/6

N2 - The isolation of single gene mutations that not only extend lifespan but also delay the onset of age-related pathology in model organisms has been instrumental in identifying key cellular processes that underlie ageing. Several of these mutations affect components of evolutionarily conserved metabolic pathways including the insulin-like growth factor/insulin signaling (IIS) and target of rapamycin (TOR) pathways. The challenges now are to understand the molecular and biochemical signaling events that mediate the observed increase in healthy lifespan when signaling via such pathways is perturbed, to identify potential targets for therapeutic interventions that could potentially be translated to humans with minimal side effects.

AB - The isolation of single gene mutations that not only extend lifespan but also delay the onset of age-related pathology in model organisms has been instrumental in identifying key cellular processes that underlie ageing. Several of these mutations affect components of evolutionarily conserved metabolic pathways including the insulin-like growth factor/insulin signaling (IIS) and target of rapamycin (TOR) pathways. The challenges now are to understand the molecular and biochemical signaling events that mediate the observed increase in healthy lifespan when signaling via such pathways is perturbed, to identify potential targets for therapeutic interventions that could potentially be translated to humans with minimal side effects.

UR - http://www.scopus.com/inward/record.url?scp=84883749827&partnerID=8YFLogxK

U2 - 10.1016/j.ddmod.2013.01.002

DO - 10.1016/j.ddmod.2013.01.002

M3 - Article

VL - 10

SP - e87–e93

IS - 2

ER -